Semaglutide CAS 910463-68-2 API
-
Price:
Negotiable
- minimum:
- Total supply:
-
Delivery term:
The date of payment from buyers deliver within days
-
seat:
Beijing
-
Validity to:
Long-term effective
-
Last update:
2024-09-26 22:21
-
Browse the number:
1
Company Profile
By certification [File Integrity]
Contact: opesyzup(Mr.)
Email: 
Telephone: 
Phone: 
Area: Beijing
Address: NO.288,Renyang, Binglun Village, Hushi Town, Xiuyu District, Putian City, Fujian Province 351146, China (CHN)
Product details
Semaglutide, for subcutaneous use, contains semaglutide, is a human GLP-1 receptor agonist (or GLP-1 analog). The main protraction mechanism of semaglutide is albumin binding, facilitated by modification of position 26 lysine with a hydrophilic spacer and a C18 fatty di-acid. Furthermore, semaglutide is modified in position 8 to provide stabilization against degradation by the enzyme dipeptidyl-peptidase 4 (DPP-4). A minor modification was made in position 34 to ensure the attachment of only one fatty di-acid. The molecular formula is C187H291N45O59 and the molecular weight is 4113.58 g/mol.link:http://www.genohopebio.com
